|Molecular classification of cancer: class discovery and class prediction by gene expression monitoring|
TR Golub, DK Slonim, P Tamayo, C Huard, M Gaasenbeek, JP Mesirov, ...
science 286 (5439), 531-537, 1999
|The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes|
JW Vardiman, J Thiele, DA Arber, RD Brunning, MJ Borowitz, A Porwit, ...
Blood 114 (5), 937-951, 2009
|The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia|
DA Arber, A Orazi, R Hasserjian, J Thiele, MJ Borowitz, MM Le Beau, ...
Blood 127 (20), 2391-2405, 2016
|The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting, Airlie House …|
NL Harris, ES Jaffe, J Diebold, G Flandrin, HK Muller-Hermelink, ...
Annals of Oncology 10 (12), 1419-1432, 1999
|Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet|
H Döhner, EH Estey, S Amadori, FR Appelbaum, T Büchner, AK Burnett, ...
Blood 115 (3), 453-474, 2010
|Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic …|
BD Cheson, JM Bennett, KJ Kopecky, T Büchner, CL Willman, EH Estey, ...
Journal of clinical oncology 21 (24), 4642-4649, 2003
|Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid …|
JC Byrd, K Mrózek, RK Dodge, AJ Carroll, CG Edwards, DC Arthur, ...
Blood, The Journal of the American Society of Hematology 100 (13), 4325-4336, 2002
|Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel|
H Döhner, E Estey, D Grimwade, S Amadori, FR Appelbaum, T Büchner, ...
Blood 129 (4), 424-447, 2017
|Aberrant CpG-island methylation has non-random and tumour-type–specific patterns|
JF Costello, MC Frühwald, DJ Smiraglia, LJ Rush, GP Robertson, X Gao, ...
Nature genetics 24 (2), 132-138, 2000
|Acute myeloid leukemia|
H Döhner, DJ Weisdorf, CD Bloomfield
New England Journal of Medicine 373 (12), 1136-1152, 2015
|All-trans-Retinoic Acid in Acute Promyelocytic Leukemia|
MS Tallman, JW Andersen, CA Schiffer, FR Appelbaum, JH Feusner, ...
New England Journal of Medicine 337 (15), 1021-1028, 1997
|Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis …|
A Tefferi, J Thiele, A Orazi, HM Kvasnicka, T Barbui, CA Hanson, G Barosi, ...
Blood, The Journal of the American Society of Hematology 110 (4), 1092-1097, 2007
|Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.|
BD Cheson, PA Cassileth, DR Head, CA Schiffer, JM Bennett, ...
Journal of Clinical Oncology 8 (5), 813-819, 1990
|Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia|
KG Roberts, Y Li, D Payne-Turner, RC Harvey, YL Yang, D Pei, ...
New England journal of medicine 371 (11), 1005-1015, 2014
|Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype|
CD Bloomfield, D Lawrence, JC Byrd, A Carroll, MJ Pettenati, ...
Cancer research 58 (18), 4173-4179, 1998
|Cytogenetics in acute leukemia|
K Mrozek, NA Heerema, CD Bloomfield
Blood reviews 18 (2), 115-136, 2004
|MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly …|
R Garzon, S Liu, M Fabbri, Z Liu, CEA Heaphy, E Callegari, S Schwind, ...
Blood, The Journal of the American Society of Hematology 113 (25), 6411-6418, 2009
|Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular …|
K Mrozek, G Marcucci, P Paschka, SP Whitman, CD Bloomfield
Blood 109 (2), 431-448, 2007
|IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study|
G Marcucci, K Maharry, YZ Wu, MD Radmacher, K Mrózek, D Margeson, ...
Journal of clinical oncology 28 (14), 2348, 2010
|MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia|
R Garzon, S Volinia, CG Liu, C Fernandez-Cymering, T Palumbo, ...
Blood, The Journal of the American Society of Hematology 111 (6), 3183-3189, 2008